Nitrite, NO and hypoxic vasodilation

Jason D. Allen, Andrew J. Gow

Research output: Contribution to journalComment/debate

11 Citations (Scopus)

Abstract

The ability to deliver oxygen and other nutrients to working tissues at a rate acutely matched to demand is the quintessential function of the cardiovascular system. Thus, an understanding of the biochemical mechanisms involved in hypoxic vasodilation remains a major goal in vascular biology. Nitric oxide, its metabolites, and oxidation status are recognized as playing important roles in this process. Previous work examining how nitrite can be converted to bioactive nitric oxide (NO) under hypoxic conditions has focused on the role of the red blood cell and haemoglobin. In a recent issue of the British Journal of Pharmacology, Pinder et al. demonstrate that plasma nitrite, in the absence of haemoglobin, is capable of increasing the maximal dilation of rabbit aortic rings under hypoxic conditions. Furthermore, they demonstrate that this relaxation can occur with or without the endothelium. This observation, even if it is only a small proportion of the relaxant activity of nitrite, highlights how NO metabolites may be involved in a variety of mechanisms of vessel control.

Original languageEnglish
Pages (from-to)1653-1654
Number of pages2
JournalBritish Journal of Pharmacology
Volume158
Issue number7
DOIs
Publication statusPublished - Dec 2009
Externally publishedYes

Fingerprint

Nitrites
Vasodilation
Nitric Oxide
Hemoglobins
Cardiovascular System
Endothelium
Blood Vessels
Dilatation
Erythrocytes
Pharmacology
Oxygen
Rabbits
Food

Keywords

  • Hypoxia
  • Nitric oxide
  • Nitrite
  • Vasodilation

ASJC Scopus subject areas

  • Pharmacology

Cite this

Nitrite, NO and hypoxic vasodilation. / Allen, Jason D.; Gow, Andrew J.

In: British Journal of Pharmacology, Vol. 158, No. 7, 12.2009, p. 1653-1654.

Research output: Contribution to journalComment/debate

Allen, Jason D. ; Gow, Andrew J. / Nitrite, NO and hypoxic vasodilation. In: British Journal of Pharmacology. 2009 ; Vol. 158, No. 7. pp. 1653-1654.
@article{eb8f38b11a7549b5954315e5fd21d9e2,
title = "Nitrite, NO and hypoxic vasodilation",
abstract = "The ability to deliver oxygen and other nutrients to working tissues at a rate acutely matched to demand is the quintessential function of the cardiovascular system. Thus, an understanding of the biochemical mechanisms involved in hypoxic vasodilation remains a major goal in vascular biology. Nitric oxide, its metabolites, and oxidation status are recognized as playing important roles in this process. Previous work examining how nitrite can be converted to bioactive nitric oxide (NO) under hypoxic conditions has focused on the role of the red blood cell and haemoglobin. In a recent issue of the British Journal of Pharmacology, Pinder et al. demonstrate that plasma nitrite, in the absence of haemoglobin, is capable of increasing the maximal dilation of rabbit aortic rings under hypoxic conditions. Furthermore, they demonstrate that this relaxation can occur with or without the endothelium. This observation, even if it is only a small proportion of the relaxant activity of nitrite, highlights how NO metabolites may be involved in a variety of mechanisms of vessel control.",
keywords = "Hypoxia, Nitric oxide, Nitrite, Vasodilation",
author = "Allen, {Jason D.} and Gow, {Andrew J.}",
year = "2009",
month = "12",
doi = "10.1111/j.1476-5381.2009.00447.x",
language = "English",
volume = "158",
pages = "1653--1654",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Nitrite, NO and hypoxic vasodilation

AU - Allen, Jason D.

AU - Gow, Andrew J.

PY - 2009/12

Y1 - 2009/12

N2 - The ability to deliver oxygen and other nutrients to working tissues at a rate acutely matched to demand is the quintessential function of the cardiovascular system. Thus, an understanding of the biochemical mechanisms involved in hypoxic vasodilation remains a major goal in vascular biology. Nitric oxide, its metabolites, and oxidation status are recognized as playing important roles in this process. Previous work examining how nitrite can be converted to bioactive nitric oxide (NO) under hypoxic conditions has focused on the role of the red blood cell and haemoglobin. In a recent issue of the British Journal of Pharmacology, Pinder et al. demonstrate that plasma nitrite, in the absence of haemoglobin, is capable of increasing the maximal dilation of rabbit aortic rings under hypoxic conditions. Furthermore, they demonstrate that this relaxation can occur with or without the endothelium. This observation, even if it is only a small proportion of the relaxant activity of nitrite, highlights how NO metabolites may be involved in a variety of mechanisms of vessel control.

AB - The ability to deliver oxygen and other nutrients to working tissues at a rate acutely matched to demand is the quintessential function of the cardiovascular system. Thus, an understanding of the biochemical mechanisms involved in hypoxic vasodilation remains a major goal in vascular biology. Nitric oxide, its metabolites, and oxidation status are recognized as playing important roles in this process. Previous work examining how nitrite can be converted to bioactive nitric oxide (NO) under hypoxic conditions has focused on the role of the red blood cell and haemoglobin. In a recent issue of the British Journal of Pharmacology, Pinder et al. demonstrate that plasma nitrite, in the absence of haemoglobin, is capable of increasing the maximal dilation of rabbit aortic rings under hypoxic conditions. Furthermore, they demonstrate that this relaxation can occur with or without the endothelium. This observation, even if it is only a small proportion of the relaxant activity of nitrite, highlights how NO metabolites may be involved in a variety of mechanisms of vessel control.

KW - Hypoxia

KW - Nitric oxide

KW - Nitrite

KW - Vasodilation

UR - http://www.scopus.com/inward/record.url?scp=71249097011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71249097011&partnerID=8YFLogxK

U2 - 10.1111/j.1476-5381.2009.00447.x

DO - 10.1111/j.1476-5381.2009.00447.x

M3 - Comment/debate

VL - 158

SP - 1653

EP - 1654

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 7

ER -